128 related articles for article (PubMed ID: 3114399)
21. [Augmentation of antitumor activity of Lactobacillus casei YIT 8018 (LC 9018) in combination with various antitumor drugs].
Matsuzaki T; Kato I; Yokokura T; Mutai M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):445-51. PubMed ID: 6200079
[TBL] [Abstract][Full Text] [Related]
22. Acceleration of granulocytic cell recovery in irradiated mice by a single subcutaneous injection of a heat-killed Lactobacillus casei preparation.
Furuse M; Tsuneoka K; Uchida K; Nomoto K
J Radiat Res; 1997 Jun; 38(2):111-20. PubMed ID: 9287464
[TBL] [Abstract][Full Text] [Related]
23. Human colony-stimulating activity-producing tumor: production of very low mouse-active colony-stimulating activity and induction of marked granulocytosis in mice.
Ikeda K; Motoyoshi K; Ishizaka Y; Hatake K; Kajigaya S; Saito M; Miura Y
Cancer Res; 1985 Sep; 45(9):4144-9. PubMed ID: 3875406
[TBL] [Abstract][Full Text] [Related]
24. Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens.
Kato I; Yokokura T; Mutai M
Microbiol Immunol; 1984; 28(2):209-17. PubMed ID: 6427563
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice.
Miake S; Nomoto K; Yokokura T; Yoshikai Y; Mutai M; Nomoto K
Infect Immun; 1985 May; 48(2):480-5. PubMed ID: 3921464
[TBL] [Abstract][Full Text] [Related]
26. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice.
Kato I; Endo K; Yokokura T
Int J Immunopharmacol; 1994 Jan; 16(1):29-36. PubMed ID: 8150553
[TBL] [Abstract][Full Text] [Related]
27. Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen.
Watanabe T; Saito H
Microbiol Immunol; 1986; 30(2):111-22. PubMed ID: 3012292
[TBL] [Abstract][Full Text] [Related]
28. Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
Chirigos MA; Schlick E; Saito T; Gruys E
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):27-33. PubMed ID: 3486334
[TBL] [Abstract][Full Text] [Related]
29. Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms.
Shida K; Kiyoshima-Shibata J; Kaji R; Nagaoka M; Nanno M
Immunology; 2009 Sep; 128(1 Suppl):e858-69. PubMed ID: 19740347
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumour effect of humoral and cellular immunities mediated by a bacterial immunopotentiator, Lactobacillus casei, in mice.
Yasutake N; Ohwaki M; Mutai M; Koide Y; Yoshida T
Cancer Immunol Immunother; 1985; 20(2):109-16. PubMed ID: 3930065
[TBL] [Abstract][Full Text] [Related]
31. Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice.
Mike A; Nagaoka N; Tagami Y; Miyashita M; Shimada S; Uchida K; Nanno M; Ohwaki M
Clin Exp Immunol; 1999 Aug; 117(2):368-75. PubMed ID: 10444272
[TBL] [Abstract][Full Text] [Related]
32. Effect of hydrocortisone and bacterial lipopolysaccharide on colony-stimulating activity production from mouse marrow adherent cells, spleen cells and peritoneal macrophages in vitro.
Aizawa S; Tsurusawa M; Mori KJ
Int J Cell Cloning; 1986 Nov; 4(6):415-23. PubMed ID: 3491167
[TBL] [Abstract][Full Text] [Related]
33. Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide, HP-5.
King AG; Talmadge JE; Badger AM; Pelus LM
Exp Hematol; 1992 Feb; 20(2):223-8. PubMed ID: 1544391
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages.
Sato K
Infect Immun; 1984 May; 44(2):445-51. PubMed ID: 6425222
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum.
Hashimoto S; Seyama Y; Yokokura T; Mutai M
Cancer Immunol Immunother; 1985; 20(2):117-21. PubMed ID: 3930066
[TBL] [Abstract][Full Text] [Related]
36. Effects of Lactobacillus casei on Pseudomonas aeruginosa infection in normal and dexamethasone-treated mice.
Saito H; Watanabe T; Horikawa Y
Microbiol Immunol; 1986; 30(3):249-59. PubMed ID: 3088397
[TBL] [Abstract][Full Text] [Related]
37. Protective and therapeutic efficacy of Lactobacillus casei against experimental murine infections due to Mycobacterium fortuitum complex.
Saito H; Tomioka H; Nagashima K
J Gen Microbiol; 1987 Oct; 133(10):2843-51. PubMed ID: 3130460
[TBL] [Abstract][Full Text] [Related]
38. Administration of an immunomodulatory azaspirane, SK&F 105685, or human recombinant interleukin 1 stimulates myelopoiesis and enhances survival from lethal irradiation in C57Bl/6 mice.
King AG; Badger AM
Exp Hematol; 1991 Aug; 19(7):624-8. PubMed ID: 1893948
[TBL] [Abstract][Full Text] [Related]
39. Effects of bacterial lipopolysaccharide on the production of colony-stimulating activity in C3H/HeJ mouse long-term bone marrow cultures.
Aizawa S; Tsurusawa M; Miyanomae T; Izumi H; Mori KJ
Leuk Res; 1985; 9(10):1277-82. PubMed ID: 3877851
[TBL] [Abstract][Full Text] [Related]
40. Stimulatory effects of purified macrophage colony-stimulating factor on murine resident peritoneal macrophages.
Ampel NM; Wing EJ; Waheed A; Shadduck RK
Cell Immunol; 1986 Feb; 97(2):344-56. PubMed ID: 3017577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
